Unlock personalized cancer care. Book a Test Now
This is to bring to your notice that SOT Therapy from RGCC is not available in Singapore
Unlock personalized cancer care. Book a Test Now
This is to bring to your notice that SOT Therapy from RGCC is not available in Singapore
CAMBISeq利用一種稱為下一代測序（NGS）的先進技術，通過對DNA和RNA的分析揭示腫瘤的基因突變，為臨床醫生提供有關癌症的重要見解。它使用患者的基因信息來預測他們對靶向治療和免疫療法的反應。這項測試識別基因中的變異，我們的科學家將其用作生物標誌物，以評估對不同類型傳統療法的敏感性。
CAMBISeq利用患者的遺傳信息來評估對免疫療法和針對癌症的靶向療法的反應。綜合遺傳分析識別超過500個基因中的變異，檢測融合，並計算腫瘤突變負擔（TMB）和微星體不穩定性（MSI）。
通過確定特定的生物標誌物，臨床醫生可以根據個性化和靶向療法選擇最佳的治療方案，以達到最大的療效。腫瘤突變負擔（TMB）是一種定量基因組生物標誌物，預測對檢查點抑制劑的敏感性。
Reserve your 15-minute free one on one discussion
CAMBISeq使科學家和臨床醫生通過腫瘤突變負擔（TMB）分數和微衛星不穩定性狀態的資料，解讀相關的遺傳信息。
憑藉這些關鍵數據，臨床醫生可以量身定制療法，以提供最有效和個性化的護理。
該測試最終提高了患者成功對抗癌症的機會。
Oncotrail has undergone rigorous evaluation to ensure high sensitivity and specificity, making it an invaluable tool for diagnostic purposes.
Through high-precision techniques, the test is used to monitor the effectiveness of a particular cancer treatment. This would objectively provide information on how well the treatment is going.
The non-invasive tracking of the cancer status would notify a treating physician whether to adjust current management or stay the course. This would be important to know in almost real-time rather than to find out much later that a treatment doesn't apply to a particular person.
整個外周血樣本，組織，FFPE組織
10-15毫升血液，最少400毫克組織，最少100毫克FFPE組織
實驗室需時3-4週
樣本收集後30天
適用於所有癌症類型
相關人士：該測試適用於所有確診癌症的患者。
A patient-centric revolution in cancer testing and monitoring. We are devoted to providing personalized tests designed with each patient’s unique genetic profile in mind.
2 Venture Drive #09-27 Vision Exchange Singapore 608526
202312501N
+65 8084 6380
IAS Accreditation Testing Laboratory
ISO 22000: 2018
Nr.: 20101200002689
ISO 22716: 2007
Nr.: 20019220006394
College of American Pathologists
Certificate of Accreditation
CAP#: 9239089
CLIA#: 99D2283882
Accreditation Certificate of Foreign Cell Processor
– Japanese Government
IAS Accreditation Medical Laboratory
ISO 45001: 2018
Nr.: 20152220006395
CLIA ID Number 99D2283882
Certificate of GMP Compliance
No. 512863-102689104
Production License for Investigational ATMPs for Human Use
Ref. No. 7282
©2025 Copy Right